AQ280
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AQ280, covering 2024-12-24 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation [Phase 1]